arrow
E

Erasmus Bachus

Lund University
H指数:20
被引数:5,510

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts
2024-10-280
OAAI
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER
2024-07-172
OA
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction
2024-05-030
OAAI
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction
2024-05-012
PRE
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER
2023-12-011
PRE
Effects of Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy - A Patient-Level Meta-Analysis of DAPA-HF and DELIVER
2023-11-070
PRE
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
2022-10-1876
OAAI
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

达格列净治疗轻度降低或保留射血分数的心力衰竭

2022-09-221.2K
OA
Dapagliflozin for heart failure according to body mass index: the DELIVER trial
2022-08-2769
OAAI